We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
–
Cap. Flow
+$165M
Cap. Flow %
94.32%
Top 10 Hldgs %
41.58%
Holding
70
New
68
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.4M
2
MRK icon
Merck
MRK
+$8.38M
3
BIIB icon
Biogen
BIIB
+$7.76M
4
ZBH icon
Zimmer Biomet
ZBH
+$7.13M
5
GILD icon
Gilead Sciences
GILD
+$5.92M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 61.37%
2 Industrials 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITMN
26
DELISTED
INTERMUNE INC
ITMN
$2.21M 1.26%
+150,000
New +$2.07M
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
$2.15M 1.23%
+70,000
New +$1.98M
DXCM icon
28
DexCom
DXCM
$33.6B
$2.13M 1.21%
+240,000
New +$1.9M
ESPR
29
DELISTED
Esperion Therapeutics
ESPR
$2.06M 1.17%
+150,000
New +$2.18M
AERI
30
DELISTED
Aerie Pharmaceuticals
AERI
$2.02M 1.15%
+112,500
New +$1.47M
NUWE icon
31
Nuwellis
NUWE
$543K
– –
0
– –
ESRX
32
DELISTED
Express Scripts Holding Company
ESRX
$1.76M 1%
+25,000
New +$1.63M
EW icon
33
Edwards Lifesciences
EW
$53.9B
$1.64M 0.94%
+150,000
New +$1.69M
MDXG icon
34
MiMedx Group
MDXG
$633M
$1.57M 0.9%
+180,000
New +$1.1M
DGX icon
35
CALL
Quest Diagnostics
DGX
$26.3B
$1.52M 0.87%
+25,000
New +$1.48M
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$135B
$1.49M 0.85%
+20,000
New +$1.39M
A icon
37
Agilent Technologies
A
$42.3B
$1.43M 0.82%
+34,950
New +$1.33M
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.89B
$1.43M 0.81%
+70,000
New +$2.08M
NVDQ
39
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.4M 0.8%
+85,000
New +$1.41M
NPSP
40
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.37M 0.78%
+45,000
New +$1.24M
UTHR icon
41
PUT
United Therapeutics
UTHR
$22.3B
$1.36M 0.78%
+15,000
New +$1.35M
AVNR
42
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$1.34M 0.77%
+400,000
New +$1.65M
CLDX icon
43
CALL
Celldex Therapeutics
CLDX
$3.47B
$1.31M 0.75%
+3,333
New +$1.28M
BRKR icon
44
Bruker
BRKR
$8.7B
$1.28M 0.73%
+65,000
New +$1.27M
IPXL
45
DELISTED
Impax Laboratories, Inc.
IPXL
$1.26M 0.72%
+50,000
New +$1.12M
IPXL
46
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
$1.19M 0.68%
+50,000
New +$1.12M
BGMS
47
Bio Green Med Solution Inc
BGMS
$4.97M
– –
0
– –
THOR
48
DELISTED
THORATEC CORPORATION
THOR
$1.1M 0.63%
+30,000
New +$1.18M
ENTA icon
49
Enanta Pharmaceuticals
ENTA
$390M
$1.09M 0.62%
+40,000
New +$969K
CNMD icon
50
CONMED
CNMD
$1.5B
$1.06M 0.61%
+25,000
New +$950K
1
2
3

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Iguana Healthcare Management, which disclosed 70 positions worth $175M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Amgen: 100,000 shares worth $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, followed by Industrials.

  • Iguana Healthcare Management's largest Q4 2013 buy was Amgen: 100,000 shares worth $11.4M.
  • Iguana Healthcare Management's ten largest holdings make up 42% of its $175M portfolio in Q4 2013.
  • Iguana Healthcare Management disclosed 70 positions in Q4 2013, its first 13F filing on record.

Based on Iguana Healthcare Management's 13F filing for Q4 2013, filed 14 Feb 2014.